Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502.
about
Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials.Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials.Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials.Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials.Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer
P2860
Q33710348-9164D854-4BC3-46E8-88FA-24BA226A8189Q33891150-89163491-D771-4FDC-B120-45BA13CC12F9Q36318341-5A130A05-DC47-40F4-8B7B-CF0BB4FDCE1DQ47124210-4AFD2A72-00B0-4C24-873F-C34B7D8B95E2Q47142559-2AA3D0FC-E500-4407-B1AC-37BD34142703Q47156794-ABAF1363-3252-44BC-B255-96BC522AEAD7Q48121803-7857D529-DF3E-4710-81FA-C053AA315A6BQ55424667-85D98D7A-269D-47E0-B60D-520795E21877Q58694209-303765C2-53A3-47A1-A3CF-E389A085A1CA
P2860
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Randomized phase III trial of ...... final results of JFMC33-0502.
@ast
Randomized phase III trial of ...... final results of JFMC33-0502.
@en
type
label
Randomized phase III trial of ...... final results of JFMC33-0502.
@ast
Randomized phase III trial of ...... final results of JFMC33-0502.
@en
prefLabel
Randomized phase III trial of ...... final results of JFMC33-0502.
@ast
Randomized phase III trial of ...... final results of JFMC33-0502.
@en
P2093
P2860
P356
P1433
P1476
Randomized phase III trial of ...... final results of JFMC33-0502.
@en
P2093
G Nishimura
J Matsuoka
K Katsumata
P2860
P304
P356
10.1093/ANNONC/MDV358
P577
2015-09-07T00:00:00Z